BIT
RCKT icon

BlackRock Institutional Trust’s Rocket Pharmaceuticals RCKT Stock Holding History

BlackRock Institutional Trust’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$2.52M Buy
103,081
+3,288
+3% +$93.8K ﹤0.01% 2981
2016
Q3 		$3.78M Buy
99,793
+1,278
+1% +$40.2K ﹤0.01% 2803
2016
Q2 		$2.93M Buy
98,515
+33,107
+51% +$1.16M ﹤0.01% 2901
2016
Q1 		$1.94M Hold
65,408
– – ﹤0.01% 3057
2015
Q4 		$2.96M Buy
65,408
+5,449
+9% +$237K ﹤0.01% 2950
2015
Q3 		$2.25M Buy
+59,959
New +$2.75M ﹤0.01% 3079

Other funds holding RCKT

RCP
Rho Capital Partners New York $20.4M AUM
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
SAM
Senzar Asset Management New York $34.7M AUM 0.56% 1-Year Est. Return

BlackRock Institutional Trust's RCKT Position: Q4 2016 in Review

BlackRock Institutional Trust increased its Rocket Pharmaceuticals (RCKT) stake by 3.3% in Q4 2016, buying an estimated $93.8K and bringing the position to 103,081 shares worth $2.52M. The position accounts for ﹤0.01% of the portfolio, ranked #2981.

BlackRock Institutional Trust first reported a position in RCKT in Q3 2015 and has held it in 6 quarters since. The position peaked at $3.78M in Q3 2016. 82 funds tracked by Wall St. Rank hold RCKT as of Q4 2016.

  • BlackRock Institutional Trust held 103,081 shares of Rocket Pharmaceuticals worth $2.52M as of Q4 2016.
  • BlackRock Institutional Trust bought 3,288 Rocket Pharmaceuticals shares in Q4 2016, an estimated $93.8K.
  • Rocket Pharmaceuticals made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #2981 holding.
  • BlackRock Institutional Trust first reported a position in Rocket Pharmaceuticals in Q3 2015 and has held it in 6 quarters since.
  • BlackRock Institutional Trust's Rocket Pharmaceuticals position peaked at $3.78M in Q3 2016.
  • 82 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.